Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03885284 · ClinicalTrials.gov registry record · Phase 1
Study of Proton Therapy in Adjuvant Pancreatic Cancer
A Phase 1 study, sponsored by Georgetown University.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT03885284 is a Phase 1 study that has completed, run by Georgetown University. The registered enrollment target is 9 participants.
The verdict
NCT03885284, a Phase 1 study, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
This trial aims to determine a safe schedule of short-course proton beam radiation therapy with adjuvant mFOLFIRINOX for patients with resected pancreatic adenocarcinoma.
Interventions
- DRUG mFOLFIRINOX
- RADIATION Proton beam radiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2019-07-15 |
| Est. Completion | 2023-11-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03885284
The ClinicalTrials.gov registry entry for NCT03885284 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which mFOLFIRINOX is the first listed.
NCT03885284 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03885284 about?
NCT03885284 is a clinical study titled "Study of Proton Therapy in Adjuvant Pancreatic Cancer". This trial aims to determine a safe schedule of short-course proton beam radiation therapy with adjuvant mFOLFIRINOX for patients with resected pancreatic adenocarcinoma.
What is the current status of trial NCT03885284?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2019-07-15. Estimated completion is 2023-11-08.
What interventions are being tested in trial NCT03885284?
The interventions under investigation include: mFOLFIRINOX (DRUG), Proton beam radiation (RADIATION).
Who is sponsoring clinical trial NCT03885284?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.